Pasar al contenido principal

IDENTIFICACION Y CARACTERIZACION FUNCIONAL DE NUEVAS VARIANTES GENETICAS RESPONSABLES DEL SINDROME HEMOFAGOCITICO: APLICACION AL DIAGNOSTICO Y TRATAMIENTO DE LA ENFERMEDAD.

PI17/00660

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2017
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings

  • Rudilla Salvador, Francesc
  • Franco Jarava, Clara
  • García Prat, Marina
  • Martín Nalda, Andrea
  • Rivière, Jacques
  • Vidal Pérez, Francisco
  • Cuscó Martín, Ivon
  • Serra Juhe, Clara
  • Baz Redón, Noelia
  • García-Patos Briones, Vicente
  • Pujol-Borrell, Ricardo
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
  • Fernández Cancio, Mónica
  • Aguiló Cucurull, Aina
Inmunodeficiencias primarias; Secuenciación de próxima generación; Secuenciación clínica del exoma, Immunodeficiències primàries; Seqüenciació de propera generació; Seqüenciació clínica d’exomes, Primary immunodeficiencies; Next generation sequencing; Clinical exome sequencing, Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders., This study was funded by Instituto de Salud Carlos III, grants PI14/00405 and PI17/00660, cofinanced by the European Regional Development Fund (ERDF).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report

  • Franco Jarava, Clara
  • Valenzuela Palafoll, Ma Irene
  • Rivière, Jacques
  • García Prat, Marina
  • Dieli Crimi, Romina
  • Castells Sarret, Neus
  • Batlle Masó, Laura
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
Chromosomal rearrangements; Primary immunodeficiencies; Syndromic immunodeficiencies, Reordenacions cromosòmiques; Immunodeficiències primàries; Immunodeficiències sindròmiques, Reordenamientos cromosómicos; Inmunodeficiencias primarias; Inmunodeficiencias sindrómicas, Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified NFKB1 haploinsufficiency as the cause. This study underscores the value of periodic reanalysis of unsolved genetic studies performed with high-throughput technologies (eg, next-generation sequencing and aCGH). This is important because of the ongoing incorporation of new data establishing the relationship between genes and diseases. In the present case, NFKB1 had not been associated with human disease at the time aCGH was performed. Eight years later, reanalysis of the genes included in the chromosome 4 deletion enabled us to identify NFKB1 haploinsufficiency as the genetic cause of our patient’s CVID. In the future, other genes included in the deletion may be linked to human disease, allowing us to better define the molecular basis of our patient’s complex clinical phenotype., This study was funded by Instituto de Salud Carlos III, grants PI17/00660 and PI20/00761, cofinanced by the European Regional Development Fund (ERDF). This study was also funded by the Jeffrey Modell Foundation. This work is supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases Network (ERN-RITA).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis

  • Viñas Gimenez, Laura
  • Rincon Perez, Rafael
  • Colobran Oriol, Roger
  • Celis, Verónica Paola
  • Dapena, José Luis
  • Sayos Ortega, Juan
  • Martínez Gallo, Mónica
  • De la Cruz Montserrat, Fco. Xavier
Histiocitosi de cèl·lules de Langerhans; Desgranulació; Exocitosi de grànuls lítics, Histiocitosis de células de Langerhans; Desgranulación; Exocitosis de gránulos líticos, Langerhans-cell-histiocytosis; Degranulation; Lytic granule exocytosis, Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory disorder. HLH can be considered as a threshold disease depending on the trigger and the residual NK-cell cytotoxicity. In this study, we analyzed the molecular and functional impact of a novel monoallelic mutation found in a patient with two episodes of HLH. A 9-month-old child was diagnosed at 2 months of age with cutaneous Langerhans cell histiocytosis (LCH). After successful treatment, the patient developed an HLH episode. At 16 month of age, the patient went through an HSCT losing the engraftment 5 months later concomitant with an HLH relapse. The genetic study revealed a monoallelic mutation in the STXBP2 gene (.pArg190Cys). We transfected COS7 cells to analyze the STXBP2-R190C expression and to test the interaction with STX11. We used the RBL-2H3 cell line expressing STXBP2-WT-EGFP or R190C-EGFP for degranulation assays. Mutation STXBP2-R190C did not affect protein expression or interaction with syntaxin-11. However, we have demonstrated that STXBP2-R190C mutation diminishes degranulation in the RBL-2H3 cell line compared with the RBL-2H3 cell line transfected with STXBP2-WT or nontransfected. These results suggest that STXBP2-R190C mutation acts as a modifier of the degranulation process producing a decrease in degranulation. Therefore, under homeostatic conditions, the presence of one copy of STXBP2-R190 could generate sufficient degranulation capacity. However, it is likely that early in life when adaptive immune system functions are not sufficiently developed, an infection may not be resolved with this genetic background, leading to a hyperinflammation syndrome and eventually develop HLH. This analysis highlights the need for functional testing of new mutations to validate their role in genetic susceptibility and to establish the best possible treatment for these patients., This work was funded by the Instituto de Salud Carlos III, grants PI17/00660 and PI18/00346, co-financed by the European Regional Development Fund (ERDF).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Case Report: Partial Uniparental Disomy Unmasks a Novel Recessive Mutation in the LYST Gene in a Patient With a Severe Phenotype of Chédiak-Higashi Syndrome

  • Boluda-Navarro, Mireia
  • Ibáñez, Mariam
  • Liquori, Alessandro
  • Franco Jarava, Clara
  • Rodríguez-Vega, Héctor
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
Síndrome de Chédiak-Higashi; LYST; Disomia uniparental, Síndrome de Chédiak-Higashi; LYST; Disomía uniparental, Chédiak-Higashi syndrome; LYST; Uniparental disomy, Chédiak-Higashi syndrome (CHS) is a rare autosomal recessive (AR) immune disorder that has usually been associated to missense, nonsense or indels mutations in the LYST gene. In this study, we describe for the first time the case of a CHS patient carrying a homozygous mutation in the LYST gene inherited as a result of a partial uniparental isodisomy (UPiD) of maternal origin. Sanger sequencing of the LYST cDNA and single nucleotide polymorphism (SNP)-arrays were performed to identify the causative mutation and to explain the molecular mechanism of inheritance, respectively. Partial-UPiD leads to a copy neutral loss of heterozygosity (CN-LOH) of the telomeric region of chromosome 1 (1q41q44), unmasking the potential effect of the mutation detected. The mutation (c.8380dupT) is an insertion located in exon 32 of the LYST gene resulting in a premature stop codon and leading to the loss of all the conserved domains at the C-terminal of the LYST protein. This would account for the severe phenotype observed. We also reviewed the only two previously reported cases of CHS as a result of a uniparental disomy. In this study, we show that the combination of different strategies, including the use of SNP-arrays, is pivotal to fine-tune the diagnosis of rare AR disorders, such as CHS. Moreover, this case highlights the relevance of uniparental disomy as a potential mechanism of CHS expression in non-consanguineous families., This study was supported by research funding from FEDER funds (CIBERONC, CB16/12/00284), Instituto de Salud Carlos III grants PI16/01113, PI17/00660, PI18/1472, PI19/00812 cofinanced by the European Regional Development Fund (ERDF); as well as from the “Conselleria de Educación, Cultura y Deporte” GV/2019/084. MB-N and AL are recipients of a fellowship from the “Asociación Española Contra El Cáncer” and the “Fundación Española de Hematología y Hemoterapia”, respectively.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Expanding the Clinical and Genetic Spectra of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing, Expected and Unexpected Findings

  • Rudilla, Francesc|||0000-0002-3099-067X
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Rivière, Jacques
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Mongay, Laura
  • Vidal, Francisco|||0000-0001-8089-4945
  • Solanich, Xavier|||0000-0002-2572-2187
  • Irastorza, Iñaki
  • Santos-Pérez, Juan Luis
  • Tercedor Sánchez, Jesús
  • Cusco, Ivon|||0000-0003-2104-9332
  • Serra, Clara
  • Baz-Redón, Noelia|||0000-0003-1704-3413
  • Fernández Cancio, Mónica|||0000-0003-1872-3488
  • Carreras, Carmen
  • Vagace, Manuel
  • García-Patos Briones, Vicente|||0000-0003-1654-6035
  • Pujol-Borrell, Ricardo|||0000-0001-7833-675X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

FHLdb, A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis

  • Viñas-Giménez, Laura|||0000-0003-2913-1154
  • Padilla Sirera, Natàlia|||0000-0002-7872-2279
  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Casals, Ferran|||0000-0002-8941-0369
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • de la Cruz, Xavier|||0000-0002-9738-8472
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Background: Primary immunodeficiencies (PIDs) are a heterogeneous group of disorders. The lack of comprehensive disease-specific mutation databases may hinder or delay classification of the genetic variants found in samples from these patients. This is especially true for familial hemophagocytic lymphohistiocytosis (FHL), a life-threatening PID classically considered an autosomal recessive condition, but with increasingly demonstrated genetic heterogeneity. Objective: The aim of this study was to build an open-access repository to collect detailed information on the known genetic variants reported in FHL. Methods: We manually reviewed more than 120 articles to identify all reported variants related to FHL. We retrieved relevant information about the allelic status, the number of patients with the same variant, and whether functional assays were done. We stored all the data retrieved in a PostgreSQL database and then built a website on top of it, using the Django framework. Results: The database designed (FHLdb) () contains comprehensive information on reported variants in the 4 genes related to FHL (PRF1, UNC13D, STXBP2, STX11). It comprises 240 missense, 69 frameshift, 51 nonsense, 51 splicing, 10 in-frame indel, 7 deep intronic, and 5 large rearrangement variants together with their allelic status, carrier(s) information, and functional evidence. All genetic variants have been classified as pathogenic, likely pathogenic, uncertain significance, likely benign or benign, according to the American College of Medical Genetics guidelines. Additionally, it integrates information from other relevant databases: clinical evidence from ClinVar and UniProt, population allele frequency from ExAC and gnomAD, and pathogenicity predictions from well-recognized tools (e.g., PolyPhen-2, SIFT). Finally, a diagram depicts the location of the variant relative to the gene exon and protein domain structures. Conclusion: FHLdb includes a broad range of data on the reported genetic variants in familial HLH genes. It is a free-access and easy-to-use resource that will facilitate the interpretation of molecular results of FHL patients, and it illustrates the potential value of disease-specific databases for other PIDs.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia, Implications for Genetic Counseling

  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Blasco-Pérez, Laura|||0000-0001-6483-5742
  • Paramonov, Ida
  • Antolín, María|||0000-0001-5623-6862
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
X-linked agammaglobulinemia (XLA) is a clinically and genetically well-defined immunodeficiency and the most common form of agammaglobulinemia. It is characterized by susceptibility to recurrent bacterial infections, profound hypogammaglobulinemia, and few or no circulating B cells. XLA is caused by mutations in the BTK gene, which encodes Bruton's tyrosine kinase (BTK). Because of its X-linked recessive inheritance pattern, XLA virtually only affects males, and the mother is the carrier of the mutation in 80-85% of the males with this condition. In the remaining 15-20% of the cases, the affected male is considered to have a de novo mutation. Here, we present the case of a child with a diagnosis of XLA caused by a missense mutation in the BTK gene (c.494G.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LRBA Deficiency in a Patient With a Novel Homozygous Mutation Due to Chromosome 4 Segmental Uniparental Isodisomy

  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Plaja Rustein, Alberto|||0000-0002-2398-1134
  • Bezdan, Daniela
  • Bosio, Mattia
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Ossowski, Stephan|||0000-0002-7416-9568
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
LRBA deficiency was first described in 2012 as an autosomal recessive disorder caused by biallelic mutations in the LRBA gene (OMIM #614700). It was initially characterized as producing early-onset hypogammaglobulinemia, autoimmune manifestations, susceptibility to inflammatory bowel disease, and recurrent infection. However, further reports expanded this phenotype (including patients without hypogammaglobulinemia) and described LRBA deficiency as a clinically variable syndrome with a wide spectrum of clinical manifestations. We present the case of a female patient who presented with type 1 diabetes, psoriasis, oral thrush, and enlarged liver and spleen at the age of 8 months. She later experienced recurrent bacterial and viral infections, including pneumococcal meningitis and Epstein Barr viremia. She underwent two consecutive stem cell transplants at the age of 8 and 9 years, and ultimately died. Samples from the patient and her parents were subjected to whole exome sequencing, which revealed a homozygous 1-bp insertion in exon 23 of the patient's LRBA gene, resulting in frameshift and premature stop codon. The patient's healthy mother was heterozygous for the mutation and her father tested wild-type. This finding suggested that either one copy of the paternal chromosome 4 bore a deletion including the LRBA locus, or the patient inherited two copies of the mutant maternal LRBA allele. The patient's sequencing data showed a 1-Mb loss of heterozygosity region in chromosome 4, including the LRBA gene. Comparative genomic hybridization array of the patient's and father's genomic DNA yielded normal findings, ruling out genomic copy number abnormalities. Here, we present the first case of LRBA deficiency due to a uniparental disomy (UPD). In contrast to classical Mendelian inheritance, UPD involves inheritance of 2 copies of a chromosomal region from only 1 parent. Specifically, our patient carried a small segmental isodisomy of maternal origin affecting 1 Mb of chromosome 4.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Case Report, Partial Uniparental Disomy Unmasks a Novel Recessive Mutation in the LYST Gene in a Patient With a Severe Phenotype of Chédiak-Higashi Syndrome

  • Boluda-Navarro, Mireia
  • Ibáñez, Mariam
  • Liquori, Alessandro|||0000-0002-4842-5986
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Rodríguez-Vega, Héctor
  • Teresa, Jaijo
  • Carreras, Carmen
  • Such, Esperanza|||0000-0001-6892-403X
  • Zúñiga, Ángel
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • Cervera, José|||0000-0001-8252-1106
Chédiak-Higashi syndrome (CHS) is a rare autosomal recessive (AR) immune disorder that has usually been associated to missense, nonsense or indels mutations in the LYST gene. In this study, we describe for the first time the case of a CHS patient carrying a homozygous mutation in the LYST gene inherited as a result of a partial uniparental isodisomy (UPiD) of maternal origin. Sanger sequencing of the LYST cDNA and single nucleotide polymorphism (SNP)-arrays were performed to identify the causative mutation and to explain the molecular mechanism of inheritance, respectively. Partial-UPiD leads to a copy neutral loss of heterozygosity (CN-LOH) of the telomeric region of chromosome 1 (1q41q44), unmasking the potential effect of the mutation detected. The mutation (c.8380dupT) is an insertion located in exon 32 of the LYST gene resulting in a premature stop codon and leading to the loss of all the conserved domains at the C-terminal of the LYST protein. This would account for the severe phenotype observed. We also reviewed the only two previously reported cases of CHS as a result of a uniparental disomy. In this study, we show that the combination of different strategies, including the use of SNP-arrays, is pivotal to fine-tune the diagnosis of rare AR disorders, such as CHS. Moreover, this case highlights the relevance of uniparental disomy as a potential mechanism of CHS expression in non-consanguineous families.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Case report, characterizing the role of the STXBP2-R190C monoallelic mutation found in a patient with hemophagocytic syndrome and Langerhans cell histiocytosis

  • Viñas-Giménez, Laura|||0000-0003-2913-1154
  • Rincón, Rafael|||0000-0002-7371-7323
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • de la Cruz, Xavier|||0000-0002-9738-8472
  • Celis, Verónica Paola
  • Dapena, José Luis|||0000-0002-6711-7479
  • Alsina Manrique, Laia|||0000-0002-3559-0018
  • Sayós, Joan|||0000-0002-4664-3461
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory disorder. HLH can be considered as a threshold disease depending on the trigger and the residual NK-cell cytotoxicity. In this study, we analyzed the molecular and functional impact of a novel monoallelic mutation found in a patient with two episodes of HLH. A 9-month-old child was diagnosed at 2 months of age with cutaneous Langerhans cell histiocytosis (LCH). After successful treatment, the patient developed an HLH episode. At 16 month of age, the patient went through an HSCT losing the engraftment 5 months later concomitant with an HLH relapse. The genetic study revealed a monoallelic mutation in the STXBP2 gene (.pArg190Cys). We transfected COS7 cells to analyze the STXBP2-R190C expression and to test the interaction with STX11. We used the RBL-2H3 cell line expressing STXBP2-WT-EGFP or R190C-EGFP for degranulation assays. Mutation STXBP2-R190C did not affect protein expression or interaction with syntaxin-11. However, we have demonstrated that STXBP2-R190C mutation diminishes degranulation in the RBL-2H3 cell line compared with the RBL-2H3 cell line transfected with STXBP2-WT or nontransfected. These results suggest that STXBP2-R190C mutation acts as a modifier of the degranulation process producing a decrease in degranulation. Therefore, under homeostatic conditions, the presence of one copy of STXBP2-R190 could generate sufficient degranulation capacity. However, it is likely that early in life when adaptive immune system functions are not sufficiently developed, an infection may not be resolved with this genetic background, leading to a hyperinflammation syndrome and eventually develop HLH. This analysis highlights the need for functional testing of new mutations to validate their role in genetic susceptibility and to establish the best possible treatment for these patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

  • Manry, Jeremy|||0000-0001-5998-2051
  • Bastard, Paul|||0000-0002-5926-8437
  • Gervais, Adrian|||0000-0002-1083-5787
  • Le Voyer, Tom|||0000-0002-7253-3135
  • Rosain, Jérémie|||0000-0002-2822-161X
  • Philippot, Quentin
  • Michailidis, Eleftherios|||0000-0002-9907-4346
  • Hoffmann, Hans-Heinrich|||0000-0003-0554-0244
  • Eto, Shohei|||0000-0002-2885-7490
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Bizien, Lucy|||0000-0001-9163-9122
  • Parra-Martínez, Alba|||0000-0002-9564-8912
  • Yang, Rui|||0000-0003-4427-2158
  • Haljasmägi, Liis|||0000-0001-7162-9808
  • Migaud, Mélanie|||0000-0003-3062-1214
  • Särekannu, Karita|||0000-0002-5984-668X
  • Maslovskaja, Julia
  • de Prost, Nicolas|||0000-0002-4833-4320
  • Tandjaoui-Lambiotte redondo, Yacine|||0000-0003-1123-4788
  • Luyt, Charles-Edouard|||0000-0001-7424-2705
  • Amador Borrero, Blanca|||0000-0001-6170-8721
  • Gaudet, Alexandre
  • Poissy, Julien|||0000-0001-6017-5353
  • Morel, Pascal
  • Richard, Pascale|||0000-0003-1864-3824
  • Cognasse, Fabrice|||0000-0001-8041-928X
  • Troya, Jesús|||0000-0001-7323-114X
  • Trouillet-Assant, Sophie|||0000-0001-6439-4705
  • Belot, Alexandre|||0000-0003-4902-5332
  • Saker, Kahina|||0000-0001-8825-5400
  • Garçon, Pierre
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Lagier, Jean-Christophe
  • Gentile, Stéphanie|||0000-0003-3858-9503
  • Rosen, Lindsey|||0000-0001-5894-3878
  • Shaw, Elana|||0000-0001-9265-8026
  • Morio, Tomohiro
  • Tanaka, Junko
  • Dalmau, David|||0000-0003-1936-478X
  • Tharaux, Pierre-Louis|||0000-0002-6062-5905
  • Sene, Damien
  • Stepanian, Alain|||0000-0002-2942-0901
  • Mégarbane, Bruno|||0000-0002-2522-2764
  • Triantafyllia, Vasiliki|||0000-0001-5832-4014
  • Fekkar, Arnaud|||0000-0001-9954-075X
  • Heath, James R.|||0000-0001-5356-4385
  • Franco, Jose Luis
  • Anaya, Juan-Manuel|||0000-0002-6444-1249
  • Solé-Violán, Jordi
  • Imberti, Luisa|||0000-0002-2075-8391
  • Biondi, Andrea
  • Bonfanti, Paolo|||0000-0001-7289-8823
  • Castagnoli, Riccardo|||0000-0003-0029-9383
  • Delmonte, Ottavia M.
  • Zhang, Yu|||0000-0002-0332-0013
  • Snow, Andrew|||0000-0002-8728-6691
  • Holland, Steven|||0000-0003-3207-5464
  • Biggs, Catherine M.
  • Moncada-Velez, Marcela|||0000-0002-3073-5345
  • Arias, Andrés Augusto|||0000-0002-9478-8403
  • Lorenzo, Lazaro|||0000-0001-6648-8684
  • Boucherit, Soraya|||0000-0002-8819-7594
  • Anglicheau, Dany|||0000-0001-5793-6174
  • Planas, Anna Maria|||0000-0002-6147-1880
  • Haerynck, Filomeen|||0000-0001-9161-7361
  • Duvlis, Sotirija|||0000-0001-8587-7386
  • Ozcelik, Tayfun|||0000-0001-5937-1082
  • Keles, Sevgi|||0000-0001-7344-8947
  • Bousfiha, Ahmed A.
  • El Bakkouri, Jalila|||0000-0003-2303-3369
  • Ramirez-Santana, Carolina|||0000-0003-2137-4899
  • Paul, Stephane|||0000-0002-8830-4273
  • Pan-Hammarström, Qiang|||0000-0003-1990-8804
  • Hammarström, Lennart|||0000-0002-8635-9609
  • Dupont, Annabelle|||0000-0002-1554-9931
  • Kurolap, Alina|||0000-0002-7005-3621
  • Metz, Christine N.|||0000-0002-1013-1691
  • Aiuti, Alessandro|||0000-0002-5398-1717
  • Casari, Giorgio|||0000-0002-0115-8980
  • Lampasona, Vito|||0000-0001-5162-8445
  • Ciceri, Fabio|||0000-0003-0873-0123
  • Barreiros, Lucila A.
  • Domínguez-Garrido, Elena|||0000-0002-2066-0511
  • Vidigal, Mateus
  • Zatz, Mayana|||0000-0003-3970-8025
  • van de Beek, Diederik|||0000-0002-4571-044X
  • Sahanic, Sabina
  • Tancevski, Ivan
  • Stepanovskyy, Yuriy|||0000-0001-6339-5490
  • Boyarchuk, Oksana|||0000-0002-1234-0040
  • Nukui, Yoko|||0000-0002-6123-5212
  • Tsumura, Miyuki
  • Vidaur, Loreto|||0000-0002-6720-4900
  • Tangye, Stuart|||0000-0002-5360-5180
  • Burrel, Sonia|||0000-0002-7783-2601
  • Duffy, Darragh|||0000-0002-8875-2308
  • Quintana-Murci, Lluis|||0000-0003-2429-6320
  • Klocperk, Adam
  • Kann, Nelli Y.|||0000-0003-3564-6496
  • Shcherbina, Anna|||0000-0002-3113-4939
  • Lau, Yu Lung|||0000-0002-4780-0289
  • Leung, Daniel|||0000-0002-9360-6233
  • Coulongeat, Matthieu|||0000-0003-1986-3546
  • Marlet, Julien|||0000-0002-8645-8703
  • Koning, Rutger|||0000-0003-3128-5072
  • Reyes, Luis Felipe|||0000-0003-1172-6539
  • Chauvineau-Grenier, Angélique
  • Venet, Fabienne|||0000-0003-0462-4235
  • Monneret, Guillaume|||0000-0002-9961-5739
  • Nussenzweig, Michel|||0000-0003-0592-8564
  • Arrestier, Romain
  • Boudhabhay, Idris
  • Baris-Feldman, Hagit|||0000-0003-4065-7560
  • Hagin, David|||0000-0003-2702-1031
  • Wauters, Joost|||0000-0002-5983-3897
  • Meyts, Isabelle|||0000-0003-1214-0302
  • Dyer, Adam|||0000-0003-1356-510X
  • Kennelly, Sean P.
  • Bourke, Nollaig M.
  • Halwani, Rabih|||0000-0002-6516-7771
  • Sharif-Askari, Fatemeh Saheb
  • Dorgham, Karim|||0000-0001-9539-3203
  • Sallette, Jérôme
  • Sedkaoui, Souad Mehlal
  • AlKhater, Suzan|||0000-0001-7315-6581
  • Rigo Bonnin, Raül|||0000-0001-5511-074X
  • Morandeira Rego, Francisco|||0000-0002-6099-1040
  • Roussel, Lucie|||0000-0001-5355-702X
  • Vinh, Donald C.|||0000-0003-1347-7767
  • Erikstrup, Christian|||0000-0001-6551-6647
  • Condino-Neto, Antonio|||0000-0002-1069-3117
  • Prando, Carolina|||0000-0002-9570-9770
  • Bondarenko, Anastasiia
  • Spaan, András|||0000-0001-5981-7259
  • Gilardin, Laurent|||0000-0001-9212-0859
  • Fellay, Jacques|||0000-0002-8240-939X
  • Lyonnet, Stanislas
  • Bilguvar, Kaya|||0000-0002-7313-7652
  • Lifton, Richard P.
  • Mane, Shrikant|||0000-0002-3267-5139
  • Anderson, Mark S.
  • Boisson, Bertrand|||0000-0001-5240-3555
  • Béziat, Vivien|||0000-0002-4020-824X
  • Zhang, Shen-Ying|||0000-0002-9449-3672
  • Andreakos, Evangelos
  • Hermine, Olivier|||0000-0003-2574-3874
  • Pujol, Aurora|||0000-0002-9606-0600
  • Peterson, Pärt|||0000-0001-6755-791X
  • Mogensen, Trine H.
  • Rowen, Lee
  • Mond, James
  • Debette, Stéphanie|||0000-0001-8675-7968
  • De Lamballerie, Xavier|||0000-0001-7895-2720
  • Burdet, Charles
  • Bouadma, Lila
  • Zins, Marie|||0000-0002-4540-4282
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • Gorochov, Guy|||0000-0003-2097-9677
  • Solanich, Xavier|||0000-0002-2572-2187
  • Susen, Sophie|||0000-0001-5953-163X
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Raoult, Didier
  • Vasse, Marc
  • Gregersen, Peter K.|||0000-0003-1613-1518
  • Piemonti, Lorenzo|||0000-0002-2172-2198
  • Rodríguez-Gallego, Carlos|||0000-0002-4344-8644
  • Notarangelo, Luigi|||0000-0002-8335-0262
  • Su, Helen C.|||0000-0002-5582-9110
  • Kisand, Kai|||0000-0002-5426-4648
  • Okada, Satoshi|||0000-0002-4622-5657
  • Puel, Anne|||0000-0003-2603-0323
  • Jouanguy, Emmanuelle|||0000-0002-7358-9157
  • Rice, Charles M.|||0000-0003-3087-8079
  • Tiberghien, Pierre|||0000-0002-9310-8322
  • Zhang, Qian|||0000-0002-9040-3289
  • Casanova, Jean-Laurent|||0000-0002-7782-4169
  • Abel, Laurent|||0000-0001-7016-6493
  • Cobat, Aurélie|||0000-0001-7209-6257
There is growing evidence that preexisting autoantibodies neutralizing type I interferons (IFNs) are strong determinants of life-threatening COVID-19 pneumonia. It is important to estimate their quantitative impact on COVID-19 mortality upon SARS-CoV-2 infection, by age and sex, as both the prevalence of these autoantibodies and the risk of COVID-19 death increase with age and are higher in men. Using an unvaccinated sample of 1,261 deceased patients and 34,159 individuals from the general population, we found that autoantibodies against type I IFNs strongly increased the SARS-CoV-2 infection fatality rate at all ages, in both men and women. Autoantibodies against type I IFNs are strong and common predictors of life-threatening COVID-19. Testing for these autoantibodies should be considered in the general population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection fatality rate (IFR) doubles with every 5 y of age from childhood onward. Circulating autoantibodies neutralizing IFN-α, IFN-ω, and/or IFN-β are found in ∼20% of deceased patients across age groups, and in ∼1% of individuals aged <70 y and in.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene, A Case Report

  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Valenzuela, Irene|||0000-0003-2350-6058
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Dieli-Crimi, Romina|||0000-0003-3413-5133
  • Castells Sarret, Neus
  • Batlle-Masó, Laura|||0000-0002-4209-176X
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified NFKB1 haploinsufficiency as the cause. This study underscores the value of periodic reanalysis of unsolved genetic studies performed with high-throughput technologies (eg, next-generation sequencing and aCGH). This is important because of the ongoing incorporation of new data establishing the relationship between genes and diseases. In the present case, NFKB1 had not been associated with human disease at the time aCGH was performed. Eight years later, reanalysis of the genes included in the chromosome 4 deletion enabled us to identify NFKB1 haploinsufficiency as the genetic cause of our patient's CVID. In the future, other genes included in the deletion may be linked to human disease, allowing us to better define the molecular basis of our patient's complex clinical phenotype.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Case Report, X-Linked SASH3 Deficiency Presenting as a Common Variable Immunodeficiency

  • Labrador Horrillo, Moises|||0000-0003-3222-2380
  • Franco-Jarava, Clara|||0000-0002-9788-189X
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Parra-Martínez, Alba|||0000-0002-9564-8912
  • Antolín, María|||0000-0001-5623-6862
  • Salgado-Perandrés, Sandra
  • Aguiló-Cucurull, Aina|||0000-0001-5622-778X
  • Martínez Gallo, Mónica|||0000-0002-7340-2161
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
SASH3 is a lymphoid-specific adaptor protein. In a recent study, SASH3 deficiency was described as a novel X-linked combined immunodeficiency with immune dysregulation, associated with impaired TCR signaling and thymocyte survival in humans. The small number of patients reported to date showed recurrent sinopulmonary, cutaneous and mucosal infections, and autoimmune cytopenia. Here we describe an adult patient previously diagnosed with common variable immunodeficiency (CVID) due to low IgG and IgM levels and recurrent upper tract infections. Two separate, severe viral infections drew our attention and pointed to an underlying T cell defect: severe varicella zoster virus (VZV) infection at the age of 4 years and bilateral pneumonia due type A influenza infection at the age of 38. Genetic testing using an NGS-based custom-targeted gene panel revealed a novel hemizygous loss-of-function variant in the SASH3 gene (c.505C.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years and account for ~ 20% of COVID-19 deaths

  • Bastard, Paul|||0000-0002-5926-8437
  • Gervais, Adrian|||0000-0002-1083-5787
  • Le Voyer, Tom|||0000-0002-7253-3135
  • Rosain, Jérémie|||0000-0002-2822-161X
  • Philippot, Quentin
  • Manry, Jeremy|||0000-0001-5998-2051
  • Michailidis, Eleftherios|||0000-0002-9907-4346
  • Hoffmann, Hans-Heinrich|||0000-0003-0554-0244
  • Eto, Shohei|||0000-0002-2885-7490
  • Garcia-Prat, Marina|||0000-0001-5387-1908
  • Bizien, Lucy|||0000-0001-9163-9122
  • Parra-Martínez, Alba|||0000-0002-9564-8912
  • Yang, Rui|||0000-0003-4427-2158
  • Haljasmägi, Liis|||0000-0001-7162-9808
  • Migaud, Mélanie|||0000-0003-3062-1214
  • Särekannu, Karita|||0000-0002-5984-668X
  • Maslovskaja, Julia
  • de Prost, Nicolas|||0000-0002-4833-4320
  • Tandjaoui-Lambiotte redondo, Yacine|||0000-0003-1123-4788
  • Luyt, Charles-Edouard|||0000-0001-7424-2705
  • Amador Borrero, Blanca|||0000-0001-6170-8721
  • Gaudet, Alexandre
  • Poissy, Julien|||0000-0001-6017-5353
  • Morel, Pascal
  • Richard, Pascale|||0000-0003-1864-3824
  • Cognasse, Fabrice|||0000-0001-8041-928X
  • Troya, Jesús|||0000-0001-7323-114X
  • Trouillet-Assant, Sophie|||0000-0001-6439-4705
  • Belot, Alexandre|||0000-0003-4902-5332
  • Saker, Kahina|||0000-0001-8825-5400
  • Garçon, Pierre
  • Rivière, Jacques G.|||0000-0003-1055-2063
  • Lagier, Jean-Christophe
  • Gentile, Stéphanie|||0000-0003-3858-9503
  • Rosen, Lindsey|||0000-0001-5894-3878
  • Shaw, Elana|||0000-0001-9265-8026
  • Morio, Tomohiro
  • Tanaka, Junko
  • Dalmau, David|||0000-0003-1936-478X
  • Tharaux, Pierre-Louis|||0000-0002-6062-5905
  • Sene, Damien
  • Stepanian, Alain|||0000-0002-2942-0901
  • Mégarbane, Bruno|||0000-0002-2522-2764
  • Triantafyllia, Vasiliki|||0000-0001-5832-4014
  • Fekkar, Arnaud|||0000-0001-9954-075X
  • Heath, James R.|||0000-0001-5356-4385
  • Franco, Jose|||0000-0001-5664-6415
  • Anaya, Juan-Manuel|||0000-0002-6444-1249
  • Solé-Violán, Jordi
  • Imberti, Luisa|||0000-0002-2075-8391
  • Biondi, Andrea
  • Bonfanti, Paolo|||0000-0001-7289-8823
  • Castagnoli, Riccardo|||0000-0003-0029-9383
  • Delmonte, Ottavia M.
  • Zhang, Yu|||0000-0002-0332-0013
  • Snow, Andrew|||0000-0002-8728-6691
  • Holland, Steven|||0000-0003-3207-5464
  • Biggs, Catherine|||0000-0002-4363-2660
  • Moncada-Velez, Marcela|||0000-0002-3073-5345
  • Arias, Andrés Augusto|||0000-0002-9478-8403
  • Lorenzo, Lazaro|||0000-0001-6648-8684
  • Boucherit, Soraya|||0000-0002-8819-7594
  • Coulibaly, Boubacar
  • Anglicheau, Dany|||0000-0001-5793-6174
  • Planas, Anna Maria|||0000-0002-6147-1880
  • Haerynck, Filomeen|||0000-0001-9161-7361
  • Duvlis, Sotirija|||0000-0001-8587-7386
  • Nussbaum, Robert L.|||0000-0003-3445-8880
  • Ozcelik, Tayfun|||0000-0001-5937-1082
  • Keles, Sevgi|||0000-0001-7344-8947
  • Bousfiha, Ahmed Aziz|||0000-0002-5011-9873
  • El Bakkouri, Jalila|||0000-0003-2303-3369
  • Ramirez-Santana, Carolina|||0000-0003-2137-4899
  • Paul, Stephane|||0000-0002-8830-4273
  • Pan-Hammarström, Qiang|||0000-0003-1990-8804
  • Hammarström, Lennart|||0000-0002-8635-9609
  • Dupont, Annabelle|||0000-0002-1554-9931
  • Kurolap, Alina|||0000-0002-7005-3621
  • Metz, Christine N.|||0000-0002-1013-1691
  • Aiuti, Alessandro|||0000-0002-5398-1717
  • Casari, Giorgio|||0000-0002-0115-8980
  • Lampasona, Vito|||0000-0001-5162-8445
  • Ciceri, Fabio|||0000-0003-0873-0123
  • Barreiros, Lucila|||0000-0002-9818-2345
  • Domínguez-Garrido, Elena|||0000-0002-2066-0511
  • Vidigal, Mateus de Castro|||0000-0002-8895-652X
  • Zatz, Mayana|||0000-0003-3970-8025
  • van de Beek, Diederik|||0000-0002-4571-044X
  • Sahanic, Sabina
  • Tancevski, Ivan
  • Stepanovskyy, Yuriy|||0000-0001-6339-5490
  • Boyarchuk, Oksana|||0000-0002-1234-0040
  • Nukui, Yoko|||0000-0002-6123-5212
  • Tsumura, Miyuki
  • Vidaur, Loreto|||0000-0002-6720-4900
  • Tangye, Stuart|||0000-0002-5360-5180
  • Burrel, Sonia|||0000-0002-7783-2601
  • Duffy, Darragh|||0000-0002-8875-2308
  • Quintana-Murci, Lluis|||0000-0003-2429-6320
  • Klocperk, Adam
  • Kann, Nelli Y.|||0000-0003-3564-6496
  • Shcherbina, Anna|||0000-0002-3113-4939
  • Lau, Yu Lung|||0000-0002-4780-0289
  • Leung, Daniel|||0000-0002-9360-6233
  • Coulongeat, Matthieu|||0000-0003-1986-3546
  • Marlet, Julien|||0000-0002-8645-8703
  • Koning, Rutger|||0000-0003-3128-5072
  • Reyes, Luis Felipe|||0000-0003-1172-6539
  • Chauvineau-Grenier, Angélique
  • Venet, Fabienne|||0000-0003-0462-4235
  • Monneret, Guillaume|||0000-0002-9961-5739
  • Nussenzweig, Michel|||0000-0003-0592-8564
  • Arrestier, Romain
  • Boudhabhay, Idris
  • Baris-Feldman, Hagit|||0000-0003-4065-7560
  • Hagin, David|||0000-0003-2702-1031
  • Wauters, Joost|||0000-0002-5983-3897
  • Meyts, Isabelle|||0000-0003-1214-0302
  • Dyer, Adam|||0000-0003-1356-510X
  • Kennelly, Sean P.
  • Bourke, Nollaig|||0000-0003-4313-6859
  • Halwani, Rabih|||0000-0002-6516-7771
  • Sharif-Askari, Narjes Saheb|||0000-0003-0482-6777
  • Dorgham, Karim|||0000-0001-9539-3203
  • Sallette, Jérome
  • Sedkaoui, Souad Mehlal
  • AlKhater, Suzan|||0000-0001-7315-6581
  • Rigo Bonnin, Raül|||0000-0001-5511-074X
  • Morandeira Rego, Francisco|||0000-0002-6099-1040
  • Roussel, Lucie|||0000-0001-5355-702X
  • Vinh, Donald C.|||0000-0003-1347-7767
  • Ostrowski, Sisse Rye|||0000-0001-5288-3851
  • Condino-Neto, Antonio|||0000-0002-1069-3117
  • Prando, Carolina|||0000-0002-9570-9770
  • Bonradenko, Anastasiia
  • Spaan, András|||0000-0001-5981-7259
  • Gilardin, Laurent|||0000-0001-9212-0859
  • Fellay, Jacques|||0000-0002-8240-939X
  • Lyonnet, Stanislas
  • Bilguvar, Kaya|||0000-0002-7313-7652
  • Lifton, Richard P.
  • Mane, Shrikant|||0000-0002-3267-5139
  • Anderson, Mark|||0000-0002-3093-4758
  • Boisson, Bertrand|||0000-0001-5240-3555
  • Béziat, Vivien|||0000-0002-4020-824X
  • Zhang, Shen-Ying|||0000-0002-9449-3672
  • Vandreakos, Evangelos|||0000-0001-5536-1661
  • Hermine, Olivier|||0000-0003-2574-3874
  • Pujol, Aurora|||0000-0002-9606-0600
  • Peterson, Pärt|||0000-0001-6755-791X
  • Mogensen, Trine Hyrup|||0000-0002-1853-9704
  • Rowen, Lee
  • Mond, James
  • Debette, Stéphanie|||0000-0001-8675-7968
  • De Lamballerie, Xavier|||0000-0001-7895-2720
  • Duval, Xavier
  • Mentré, France
  • Zins, Marie|||0000-0002-4540-4282
  • Soler Palacín, Pere|||0000-0002-0346-5570
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • Gorochov, Guy|||0000-0003-2097-9677
  • Solanich, Xavier|||0000-0002-2572-2187
  • Susen, Sophie|||0000-0001-5953-163X
  • Martínez Picado, Francisco Javier|||0000-0002-4916-2129
  • Raoult, Didier
  • Vasse, Marc
  • Gregersen, Peter K.|||0000-0003-1613-1518
  • Piemonti, Lorenzo|||0000-0002-2172-2198
  • Rodríguez-Gallego, Carlos|||0000-0002-4344-8644
  • Notarangelo, Luigi|||0000-0002-8335-0262
  • Su, Helen C.|||0000-0002-5582-9110
  • Kisand, Kai|||0000-0002-5426-4648
  • Okada, Satoshi|||0000-0002-4622-5657
  • Puel, Anne|||0000-0003-2603-0323
  • Jouanguy, Emmanuelle|||0000-0002-7358-9157
  • Rice, Charles M.|||0000-0003-3087-8079
  • Tiberghien, Pierre|||0000-0002-9310-8322
  • Zhang, Qian|||0000-0002-9040-3289
  • Cobat, Aurélie|||0000-0001-7209-6257
  • Abel, Laurent|||0000-0001-7016-6493
  • Casanova, Jean-Laurent|||0000-0002-7782-4169
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10ng/mL, in plasma diluted 1 to 10) of IFN-α and/or -ω are found in about 10% of patients with critical COVID-19 pneumonia, but not in subjects with asymptomatic infections. We detect auto-Abs neutralizing 100-fold lower, more physiological, concentrations of IFN-α and/or -ω (100pg/mL, in 1/10 dilutions of plasma) in 13.6% of 3,595 patients with critical COVID-19, including 21% of 374 patients.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis

  • Viñas Gimenez, Laura
  • Rincon Perez, Rafael
  • Colobran Oriol, Roger
  • Celis, Verónica Paola
  • Dapena, José Luis
  • Sayos Ortega, Juan
  • Martínez Gallo, Mónica
  • De la Cruz Montserrat, Fco. Xavier
Histiocitosi de cèl·lules de Langerhans; Desgranulació; Exocitosi de grànuls lítics, Histiocitosis de células de Langerhans; Desgranulación; Exocitosis de gránulos líticos, Langerhans-cell-histiocytosis; Degranulation; Lytic granule exocytosis, Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory disorder. HLH can be considered as a threshold disease depending on the trigger and the residual NK-cell cytotoxicity. In this study, we analyzed the molecular and functional impact of a novel monoallelic mutation found in a patient with two episodes of HLH. A 9-month-old child was diagnosed at 2 months of age with cutaneous Langerhans cell histiocytosis (LCH). After successful treatment, the patient developed an HLH episode. At 16 month of age, the patient went through an HSCT losing the engraftment 5 months later concomitant with an HLH relapse. The genetic study revealed a monoallelic mutation in the STXBP2 gene (.pArg190Cys). We transfected COS7 cells to analyze the STXBP2-R190C expression and to test the interaction with STX11. We used the RBL-2H3 cell line expressing STXBP2-WT-EGFP or R190C-EGFP for degranulation assays. Mutation STXBP2-R190C did not affect protein expression or interaction with syntaxin-11. However, we have demonstrated that STXBP2-R190C mutation diminishes degranulation in the RBL-2H3 cell line compared with the RBL-2H3 cell line transfected with STXBP2-WT or nontransfected. These results suggest that STXBP2-R190C mutation acts as a modifier of the degranulation process producing a decrease in degranulation. Therefore, under homeostatic conditions, the presence of one copy of STXBP2-R190 could generate sufficient degranulation capacity. However, it is likely that early in life when adaptive immune system functions are not sufficiently developed, an infection may not be resolved with this genetic background, leading to a hyperinflammation syndrome and eventually develop HLH. This analysis highlights the need for functional testing of new mutations to validate their role in genetic susceptibility and to establish the best possible treatment for these patients., This work was funded by the Instituto de Salud Carlos III, grants PI17/00660 and PI18/00346, co-financed by the European Regional Development Fund (ERDF).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Common Variable Immunodeficiency and Neurodevelopmental Delay Due to a 13Mb Deletion on Chromosome 4 Including the NFKB1 Gene: A Case Report

  • Franco Jarava, Clara
  • Valenzuela Palafoll, Ma Irene
  • Rivière, Jacques
  • García Prat, Marina
  • Dieli Crimi, Romina
  • Castells Sarret, Neus
  • Batlle Masó, Laura
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
Chromosomal rearrangements; Primary immunodeficiencies; Syndromic immunodeficiencies, Reordenacions cromosòmiques; Immunodeficiències primàries; Immunodeficiències sindròmiques, Reordenamientos cromosómicos; Inmunodeficiencias primarias; Inmunodeficiencias sindrómicas, Syndromic immunodeficiencies are a heterogeneous group of inborn errors of immunity that can affect the development of non-immune organs and systems. The genetic basis of these immunodeficiencies is highly diverse, ranging from monogenic defects to large chromosomal aberrations. Antibody deficiency is the most prevalent immunological abnormality in patients with syndromic immunodeficiencies caused by chromosomal rearrangements, and usually manifests as a common variable immunodeficiency (CVID)-like phenotype. Here we describe a patient with a complex phenotype, including neurodevelopmental delay, dysmorphic features, malformations, and CVID (hypogammaglobulinemia, reduced pre-switch and switch memory B cells, and impaired vaccine response). Microarray-based comparative genomic hybridization (aCGH) revealed a 13-Mb deletion on chromosome 4q22.2-q24 involving 53 genes, some of which were related to the developmental manifestations in our patient. Although initially none of the affected genes could be linked to his CVID phenotype, subsequent reanalysis identified NFKB1 haploinsufficiency as the cause. This study underscores the value of periodic reanalysis of unsolved genetic studies performed with high-throughput technologies (eg, next-generation sequencing and aCGH). This is important because of the ongoing incorporation of new data establishing the relationship between genes and diseases. In the present case, NFKB1 had not been associated with human disease at the time aCGH was performed. Eight years later, reanalysis of the genes included in the chromosome 4 deletion enabled us to identify NFKB1 haploinsufficiency as the genetic cause of our patient’s CVID. In the future, other genes included in the deletion may be linked to human disease, allowing us to better define the molecular basis of our patient’s complex clinical phenotype., This study was funded by Instituto de Salud Carlos III, grants PI17/00660 and PI20/00761, cofinanced by the European Regional Development Fund (ERDF). This study was also funded by the Jeffrey Modell Foundation. This work is supported by the European Reference Network for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases Network (ERN-RITA).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Expanding the clinical and genetic spectra of primary immunodeficiency-related disorders with clinical exome sequencing: expected and unexpected findings

  • Rudilla Salvador, Francesc
  • Franco Jarava, Clara
  • García Prat, Marina
  • Martín Nalda, Andrea
  • Rivière, Jacques
  • Vidal Pérez, Francisco
  • Cuscó Martín, Ivon
  • Serra Juhe, Clara
  • Baz Redón, Noelia
  • García-Patos Briones, Vicente
  • Pujol-Borrell, Ricardo
  • Soler Palacín, Pere
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
  • Fernández Cancio, Mónica
  • Aguiló Cucurull, Aina
Inmunodeficiencias primarias; Secuenciación de próxima generación; Secuenciación clínica del exoma, Immunodeficiències primàries; Seqüenciació de propera generació; Seqüenciació clínica d’exomes, Primary immunodeficiencies; Next generation sequencing; Clinical exome sequencing, Primary immunodeficiencies (PIDs) refer to a clinically, immunologically, and genetically heterogeneous group of over 350 disorders affecting development or function of the immune system. The increasing use of next-generation sequencing (NGS) technology has greatly facilitated identification of genetic defects in PID patients in daily clinical practice. Several NGS approaches are available, from the unbiased whole exome sequencing (WES) to specific gene panels. Here, we report on a 3-year experience with clinical exome sequencing (CES) for genetic diagnosis of PIDs. We used the TruSight One sequencing panel, which includes 4,813 disease-associated genes, in 61 unrelated patients (pediatric and adults). The analysis was done in 2 steps: first, we focused on a virtual PID panel and then, we expanded the analysis to the remaining genes. A molecular diagnosis was achieved in 19 (31%) patients: 12 (20%) with mutations in genes included in the virtual PID panel and 7 (11%) with mutations in other genes. These latter cases provided interesting and somewhat unexpected findings that expand the clinical and genetic spectra of PID-related disorders, and are useful to consider in the differential diagnosis. We also discuss 5 patients (8%) with incomplete genotypes or variants of uncertain significance. Finally, we address the limitations of CES exemplified by 7 patients (11%) with negative results on CES who were later diagnosed by other approaches (more specific PID panels, WES, and comparative genomic hybridization array). In summary, the genetic diagnosis rate using CES was 31% (including a description of 12 novel mutations), which rose to 42% after including diagnoses achieved by later use of other techniques. The description of patients with mutations in genes not included in the PID classification illustrates the heterogeneity and complexity of PID-related disorders., This study was funded by Instituto de Salud Carlos III, grants PI14/00405 and PI17/00660, cofinanced by the European Regional Development Fund (ERDF).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Case Report: Partial Uniparental Disomy Unmasks a Novel Recessive Mutation in the LYST Gene in a Patient With a Severe Phenotype of Chédiak-Higashi Syndrome

  • Boluda-Navarro, Mireia
  • Ibáñez, Mariam
  • Liquori, Alessandro
  • Franco Jarava, Clara
  • Rodríguez-Vega, Héctor
  • Colobran Oriol, Roger
  • Martínez Gallo, Mónica
Síndrome de Chédiak-Higashi; LYST; Disomia uniparental, Síndrome de Chédiak-Higashi; LYST; Disomía uniparental, Chédiak-Higashi syndrome; LYST; Uniparental disomy, Chédiak-Higashi syndrome (CHS) is a rare autosomal recessive (AR) immune disorder that has usually been associated to missense, nonsense or indels mutations in the LYST gene. In this study, we describe for the first time the case of a CHS patient carrying a homozygous mutation in the LYST gene inherited as a result of a partial uniparental isodisomy (UPiD) of maternal origin. Sanger sequencing of the LYST cDNA and single nucleotide polymorphism (SNP)-arrays were performed to identify the causative mutation and to explain the molecular mechanism of inheritance, respectively. Partial-UPiD leads to a copy neutral loss of heterozygosity (CN-LOH) of the telomeric region of chromosome 1 (1q41q44), unmasking the potential effect of the mutation detected. The mutation (c.8380dupT) is an insertion located in exon 32 of the LYST gene resulting in a premature stop codon and leading to the loss of all the conserved domains at the C-terminal of the LYST protein. This would account for the severe phenotype observed. We also reviewed the only two previously reported cases of CHS as a result of a uniparental disomy. In this study, we show that the combination of different strategies, including the use of SNP-arrays, is pivotal to fine-tune the diagnosis of rare AR disorders, such as CHS. Moreover, this case highlights the relevance of uniparental disomy as a potential mechanism of CHS expression in non-consanguineous families., This study was supported by research funding from FEDER funds (CIBERONC, CB16/12/00284), Instituto de Salud Carlos III grants PI16/01113, PI17/00660, PI18/1472, PI19/00812 cofinanced by the European Regional Development Fund (ERDF); as well as from the “Conselleria de Educación, Cultura y Deporte” GV/2019/084. MB-N and AL are recipients of a fellowship from the “Asociación Española Contra El Cáncer” and the “Fundación Española de Hematología y Hemoterapia”, respectively.